down arrow

Bioceltix SA

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: PLBCLTX00019
PLN
73.50
-41.5 (-36.09%)

Oct 02

WAR

 View all stocks in this country
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Biogened SA
Celon Pharma SA
Ryvu Therapeutics SA
Captor Therapeutics SA
Synthaverse SA
BIOTON SA
Bioceltix SA
Molecure SA
E-shopping Group SA

Why is Bioceltix SA ?

Icon
Unrated Stock - No Analysis Available
stock-recommendationReal-Time Research Report

Verdict Report

Icon
No Data Found

Is Bioceltix SA for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Bioceltix SA
-100.0%
0.56
38.40%
Poland WIG
43.29%
2.67
16.21%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
-0.20%
EBIT Growth (5y)
-226.32%
EBIT to Interest (avg)
-14.01
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.86
Sales to Capital Employed (avg)
-0.02
Tax Ratio
0.24%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
7.42
EV to EBIT
-23.14
EV to EBITDA
-23.97
EV to Capital Employed
63.23
EV to Sales
NA
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-273.26%
ROE (Latest)
-25.42%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

5What is working for the Company
NET PROFIT(HY)

Higher at PLN -10.75 MM

RAW MATERIAL COST(Y)

Fallen by 0% (YoY

CASH AND EQV(HY)

Highest at PLN 117.63 MM

-7What is not working for the Company
OPERATING CASH FLOW(Y)

Lowest at PLN -18.31 MM

NET PROFIT(HY)

At PLN -10.75 MM has Grown at -45.5%

INVENTORY TURNOVER RATIO(HY)

Lowest at 0 times

Here's what is working for Bioceltix SA

Net Profit
Higher at PLN -10.75 MM
than preceding 12 month period ended Jun 2026
MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (PLN MM)

Cash and Eqv
Highest at PLN 117.63 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Raw Material Cost
Fallen by 0% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Bioceltix SA

Net Profit
At PLN -10.75 MM has Grown at -45.5%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is negative

Net Profit (PLN MM)

Operating Cash Flow
Lowest at PLN -18.31 MM
in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (PLN MM)

Inventory Turnover Ratio
Lowest at 0 times
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Footer loading